Corrigendum to: Ursolic Acid Inhibits Proliferation and Induces Apoptosis in Human Glioblastoma Cell Lines U251 by Suppressing TGF-β1/miR-21/PDCD4 Pathway (Basic & Clinical Pharmacology & Toxicology, (2012), (n/a), 10.1111/j.1742-7843.2012.00870.x);Ursolic Acid Inhibits Proliferation and Induces Apoptosis in Human Glioblastoma Cell Lines U251 by Suppressing TGF-β1/miR-21/PDCD4 Pathway

Basic and Clinical Pharmacology and Toxicology

Volumn 111, Issue 2, 2012, Pages 106-112

  Wang, Jian ^a   Li, Yongli ^a   Wang, Xiaofeng ^a   Jiang, Chuanlu ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; MICRORNA 21; PROGRAMMED CELL DEATH 4 PROTEIN; PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRYPAN BLUE; UNCLASSIFIED DRUG; URSOLIC ACID;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL ASSAY; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; ELECTRON MICROSCOPY; ENZYME ACTIVATION; FLUORESCENCE MICROSCOPY; GENE OVEREXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TIME; TRYPAN BLUE DYE EXCLUSION ASSAY; WESTERN BLOTTING;

EID: 84864005483     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.13314     Document Type: Erratum

References (37)

1. Jansen M, Yip S, Louis DN. Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers. Lancet Neurol 2010;9:717-26.
2. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 2007;21:2683-710.
3. Karmakar S, Banik NL, Patel SJ, Ray SK. Combination of all-trans retinoic acid and taxol regressed glioblastoma T98G xenografts in nude mice. Apoptosis 2007;12:2077-87.
4. Kyritsis AP, Levin VA. An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting. Cancer Chemother Pharmacol 2011;67:971-83.
5. Soffietti R, Ruda R, Trevisan E. New chemotherapy options for the treatment of malignant gliomas. Anticancer Drugs 2007;18:621-32.
6. Huang HC, Huang CY, Lin-Shiau SY, Lin JK. Ursolic acid inhibits IL-1beta or TNF-alpha-induced C6 glioma invasion through suppressing the association ZIP/p62 with PKC-zeta and downregulating the MMP-9 expression. Mol Carcinog 2009;48:517-31.
7. Ikeda Y, Murakami A, Ohigashi H. Ursolic acid: an anti- and pro-inflammatory triterpenoid. Mol Nutr Food Res 2008;52:26-42.
8. Shanmugam MK, Rajendran P, Li F, Nema T, Vali S, Abbasi T et al. Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice. J Mol Med (Berl) 2011;89:713-27.
9. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005;65:6029-33.
10. Kwak HJ, Kim YJ, Chun KR, Woo YM, Park SJ, Jeong JA et al. Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene 2011;30:2433-42.
11. Zhang YX, Kong CZ, Wang LH, Li JY, Liu XK, Xu B et al. Ursolic acid overcomes Bcl-2-mediated resistance to apoptosis in prostate cancer cells involving activation of JNK-induced Bcl-2 phosphorylation and degradation. J Cell Biochem 2010;109:764-73.
12. Wang X, Zhang F, Yang L, Mei Y, Long H, Zhang X et al. Ursolic acid inhibits proliferation and induces apoptosis of cancer cells in vitro and in vivo. J Biomed Biotechnol 2011;2011:419343.
13. Shan JZ, Xuan YY, Zheng S, Dong Q, Zhang SZ. Ursolic acid inhibits proliferation and induces apoptosis of HT-29 colon cancer cells by inhibiting the EGFR/MAPK pathway. J Zhejiang Univ Sci B 2009;10:668-74.
14. Wang JS, Ren TN, Xi T. Ursolic acid induces apoptosis by suppressing the expression of FoxM1 in MCF-7 human breast cancer cells. Med Oncol 2012;29:10-5.
15. Chu W, Li X, Li C, Wan L, Shi H, Song X et al. TGFBR3, a potential negative regulator of TGF-beta signaling, protects cardiac fibroblasts from hypoxia-induced apoptosis. J Cell Physiol 2011;226:2586-94.
16. 2+-dependent manner. Int J Cardiol 2010;143:86-93.
17. Haga N, Naito M, Seimiya H, Tomida A, Dong J, Tsuruo T. 2-Deoxyglucose inhibits chemotherapeutic drug-induced apoptosis in human monocytic leukemia U937 cells with inhibition of c-Jun N-terminal kinase 1/stress-activated protein kinase activation. Int J Cancer 1998;76:86-90.
18. Tsuruo T, Naito M, Tomida A, Fujita N, Mashima T, Sakamoto H et al. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci 2003;94:15-21.
19. Huang P, Oliff A. Signaling pathways in apoptosis as potential targets for cancer therapy. Trends Cell Biol 2001;11:343-8.
20. Kim DK, Baek JH, Kang CM, Yoo MA, Sung JW, Chung HY et al. Apoptotic activity of ursolic acid may correlate with the inhibition of initiation of DNA replication. Int J Cancer 2000;87:629-36.
21. Lai MY, Leung HW, Yang WH, Chen WH, Lee HZ. Up-regulation of matrix metalloproteinase family gene involvement in ursolic acid-induced human lung non-small carcinoma cell apoptosis. Anticancer Res 2007;27:145-53.
22. Zhang W, Li Y, Zhang G, Lu J, Ou H. [Experimental study on MCF-7 cell apoptosis induced by ursolic acid]. Zhong Yao Cai 2005;28:297-301.
23. Liu XS, Jiang J. Induction of apoptosis and regulation of the MAPK pathway by ursolic acid in human leukemia K562 cells. Planta Med 2007;73:1192-4.
24. Andersson D, Liu JJ, Nilsson A, Duan RD. Ursolic acid inhibits proliferation and stimulates apoptosis in HT29 cells following activation of alkaline sphingomyelinase. Anticancer Res 2003;23:3317-22.
25. Zhang GP, Lu YY, Lv JC, Ou HJ. [Effect of ursolic acid on caspase-3 and PARP expression of human MCF-7 cells]. Zhongguo Zhong Yao Za Zhi 2006;31:141-4.
26. Hsu YL, Kuo PL, Lin CC. Proliferative inhibition, cell-cycle dysregulation, and induction of apoptosis by ursolic acid in human non-small cell lung cancer A549 cells. Life Sci 2004;75:2303-16.
27. Kassi E, Papoutsi Z, Pratsinis H, Aligiannis N, Manoussakis M, Moutsatsou P. Ursolic acid, a naturally occurring triterpenoid, demonstrates anticancer activity on human prostate cancer cells. J Cancer Res Clin Oncol 2007;133:493-500.
28. Papagiannakopoulos T, Shapiro A, Kosik KS. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 2008;68:8164-72.
29. Ren Y, Zhou X, Mei M, Yuan XB, Han L, Wang GX et al. MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol. BMC Cancer 2010;10:27.
30. Cheng Y, Zhu P, Yang J, Liu X, Dong S, Wang X et al. Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res 2010;87:431-9.
31. Lawler S, Chiocca EA. Emerging functions of microRNAs in glioblastoma. J Neurooncol 2009;92:297-306.
32. Bhatti I, Lee A, James V, Hall RI, Lund JN, Tufarelli C et al. Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. J Gastrointest Surg 2011;15:199-208.
33. Mei M, Ren Y, Zhou X, Yuan XB, Han L, Wang GX et al. Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells. Technol Cancer Res Treat 2010;9:77-86.
34. Mudduluru G, George-William JN, Muppala S, Asangani IA, Kumarswamy R, Nelson LD et al. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci Rep 2011;31:185-97.
35. Davis BN, Hilyard AC, Lagna G, Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008;454:56-61.
36. Zavadil J, Narasimhan M, Blumenberg M, Schneider RJ. Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs 2007;185:157-61.
37. Murakami S, Takashima H, Sato-Watanabe M, Chonan S, Yamamoto K, Saitoh M et al. Ursolic acid, an antagonist for transforming growth factor (TGF)-beta1. FEBS Lett 2004;566:55-9.